Phio Pharmaceuticals annual operating margin
2012
2013
2015
2016
2017
2018
2019
Phio Pharmaceuticals's operating margin was −42,795.24% for fiscal 2019.
View full Phio Pharmaceuticals company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2019 | 2019-12-31 | −42,795.24% | −37459.01 pp |
| 2018 | 2018-12-31 | −5,336.23% | +88410.43 pp |
| 2017 | 2017-12-31 | −93,746.67% | −46299.30 pp |
| 2016 | 2016-12-31 | −47,447.37% | −17338.54 pp |
| 2015 | 2015-12-31 | −30,108.82% | −24858.45 pp |
| 2013 | 2013-12-31 | −5,250.38% | +8125.91 pp |
| 2012 | 2012-12-31 | −13,376.29% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2019 | 2019-03-31 | −10,219.05% | +14403.17 pp |
| Q3 2018 | 2018-09-30 | −2,617.54% | +21993.57 pp |
| Q2 2018 | 2018-06-30 | −3,274.14% | +19175.86 pp |
| Q1 2018 | 2018-03-31 | −9,734.78% | −1070.08 pp |
| Q3 2016 | 2016-09-30 | −24,622.22% | −16725.67 pp |
| Q2 2016 | 2016-06-30 | −24,611.11% | −15924.90 pp |
| Q1 2016 | 2016-03-31 | −22,450.00% | −20198.91 pp |
| Q1 2015 | 2015-03-31 | −8,664.71% | −7791.37 pp |
| Q1 2014 | 2014-03-31 | −7,896.55% | +19261.94 pp |
| Q4 2013 | 2013-12-31 | −8,686.21% | −5710.77 pp |
| Q3 2013 | 2013-09-30 | −2,251.09% | — |
| Q2 2013 | 2013-06-30 | −873.33% | — |
| Q1 2013 | 2013-03-31 | −27,158.49% | — |
| Q3 2012 | 2012-09-30 | −2,975.44% | — |
Over the last five reported fiscal years, Phio Pharmaceuticals's operating margin decreased from −5,250.38% to −42,795.24%, a change of −37544.86 percentage points. The latest reported quarter, Q1 2019, shows −10,219.05%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Phio Pharmaceuticals filings at SEC.gov ↗